Search

Your search keyword '"Haas, Oskar"' showing total 835 results

Search Constraints

Start Over You searched for: Author "Haas, Oskar" Remove constraint Author: "Haas, Oskar" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
835 results on '"Haas, Oskar"'

Search Results

1. Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia: Long-term results of the AIEOP-BFM ALL 2000 trial in Austria

2. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

4. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

5. Body‐wide chimerism and mosaicism are predominant causes of naturally occurring ABO discrepancies.

6. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group

7. Retrospective identification of the first cord blood–transplanted severe aplastic anemia in a STAT1-associated chronic mucocutaneous candidiasis family: case report, review of literature and pathophysiologic background.

8. Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia.

10. Hyperdiploid acute lymphoblastic leukemia in children with LZTR1 germline variants

11. A single‐center cohort study of patients with hereditary spherocytosis in Central Europe reveals a high frequency of novel disease‐causing genotypes

14. Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic Leukemia

19. Deciphering the Somatic and Germline Structural Variation Landscape in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia By Whole Genome Optical Mapping

20. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

22. Lmo2 expression defines tumor cell identity during T‐cell leukemogenesis

25. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group

26. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

27. Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2–harboring clones as main relapse-driving force in childhood ALL

28. Perception and management of cancer predisposition in pediatric cancer centers: A European‐wide questionnaire‐based survey.

30. Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

33. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling

34. Improved Outcome in Patients with Chronic Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Over the Past 25 Years: A Single-Center Experience

39. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

41. Copy Number Changes and Allele Distribution Patterns of Chromosome 21 in B Cell Precursor Acute Lymphoblastic Leukemia

45. Epigenetic regulator genes direct lineage switching in MLL-AF4 leukaemia

50. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

Catalog

Books, media, physical & digital resources